1. Home
  2. UNCY vs UFI Comparison

UNCY vs UFI Comparison

Compare UNCY & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNCY
  • UFI
  • Stock Information
  • Founded
  • UNCY 2016
  • UFI 1969
  • Country
  • UNCY United States
  • UFI United States
  • Employees
  • UNCY N/A
  • UFI N/A
  • Industry
  • UNCY Biotechnology: Pharmaceutical Preparations
  • UFI Textiles
  • Sector
  • UNCY Health Care
  • UFI Consumer Discretionary
  • Exchange
  • UNCY Nasdaq
  • UFI Nasdaq
  • Market Cap
  • UNCY 74.2M
  • UFI 84.6M
  • IPO Year
  • UNCY 2021
  • UFI N/A
  • Fundamental
  • Price
  • UNCY $4.42
  • UFI $3.85
  • Analyst Decision
  • UNCY Strong Buy
  • UFI
  • Analyst Count
  • UNCY 5
  • UFI 0
  • Target Price
  • UNCY $41.60
  • UFI N/A
  • AVG Volume (30 Days)
  • UNCY 459.6K
  • UFI 46.8K
  • Earning Date
  • UNCY 11-14-2025
  • UFI 11-04-2025
  • Dividend Yield
  • UNCY N/A
  • UFI N/A
  • EPS Growth
  • UNCY N/A
  • UFI N/A
  • EPS
  • UNCY N/A
  • UFI N/A
  • Revenue
  • UNCY N/A
  • UFI $559,646,000.00
  • Revenue This Year
  • UNCY N/A
  • UFI $7.18
  • Revenue Next Year
  • UNCY $19,392.60
  • UFI $6.72
  • P/E Ratio
  • UNCY N/A
  • UFI N/A
  • Revenue Growth
  • UNCY N/A
  • UFI N/A
  • 52 Week Low
  • UNCY $3.71
  • UFI $4.01
  • 52 Week High
  • UNCY $11.00
  • UFI $6.49
  • Technical
  • Relative Strength Index (RSI)
  • UNCY 43.93
  • UFI 24.28
  • Support Level
  • UNCY $4.32
  • UFI $4.33
  • Resistance Level
  • UNCY $4.63
  • UFI $4.69
  • Average True Range (ATR)
  • UNCY 0.29
  • UFI 0.20
  • MACD
  • UNCY -0.08
  • UFI -0.05
  • Stochastic Oscillator
  • UNCY 12.61
  • UFI 0.00

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: